| Primary peritoneal spindle cell sarcoma presented with massive ascites: a case report. | |
| | |
MedLine Citation:
|
PMID: 20148470 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Soft tissue sarcomas (STSs) are a heterogeneous group of rare neoplasms originating from the embryonic mesoderm and mesenchymal cells. Primary peritoneal sarcomas have been reported as leiomyosarcoma, liposarcoma and carcinosarcoma. However, primary peritoneal spindle cell sarcoma has never been reported in the literature. Herein, we report on a 38-year-old woman with massive ascites diagnosed as primary peritoneal spindle cell sarcoma. Following doxorubicin and ifosfamide chemotherapy, her symptoms improved and ascites regressed. Other primary peritoneal sarcomas rarely cause massive ascites. We suggest that in patients presenting with massive exudative ascites associated with malignancy, primary peritoneal sarcomas should be also considered in the differential diagnosis. |
| | |
Authors:
|
A Bilici; K Uygun; E Altun; E Karci; Y Gurbuz; A Semih Dogan |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of B.U.ON. : official journal of the Balkan Union of Oncology Volume: 14 ISSN: 1107-0625 ISO Abbreviation: J BUON Publication Date: 2009 Oct-Dec |
Date Detail:
|
Created Date: 2010-02-11 Completed Date: 2010-03-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883428 Medline TA: J BUON Country: Greece |
Other Details:
|
Languages: eng Pagination: 721-3 Citation Subset: IM |
Affiliation:
|
Department of Medical Oncology, Dr. Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey. ahmetknower@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antineoplastic Combined Chemotherapy Protocols / therapeutic use* Ascites / drug therapy, etiology*, pathology Doxorubicin / administration & dosage Female Humans Ifosfamide / administration & dosage Peritoneal Neoplasms / complications*, diagnosis, drug therapy Prognosis Sarcoma / complications*, diagnosis, drug therapy Soft Tissue Neoplasms / complications*, diagnosis, drug therapy Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
23214-92-8/Doxorubicin; 3778-73-2/Ifosfamide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Metastatic melanoma: case report of a patient with seventeen months of complete remission, five year...
Next Document: Bernard Peyrilhe (1737-1804) and the first experimental transmission of cancer.